Skip to content
POM-V Prescription Required Companion Animal

Nobivac Respira Bb Suspension for Injection in Pre-filled Syringe for Dogs

Active ingredient: Bordetella bronchiseptica

Form

Injection

Species

Dogs

Manufacturer

Intervet International B.V.

VMD MA No.

06376/3024

What it's used for

Onset of immunity: 2 weeks. Duration of immunity: 7 months after primary vaccination. 1 year after revaccination. AN: 02650/2024Page 2 of 6

Full indications, dosage and side effects ↓
View official SPC (PDF)

The prescription itself has a price. See what practices near you charge for a consultation and the written prescription fee.

Paying less for Bordetella bronchiseptica

  1. 1

    Ask your vet for a written prescription

    They must provide one on request. Under the CMA Order the fee is capped at £21 from 2027.

  2. 2

    Fill it at a registered online retailer

    The CMA found online pharmacies 50–60% cheaper than practice dispensing on common medicines — typically £200–£300 a year.

Prescription required

Your vet must provide a written prescription on request. You can then purchase from any licensed online retailer.

Clinical information

Nobivac Respira Bb Suspension for Injection in Pre-filled Syringe for Dogs — SPC Details

Source: VMD Summary of Product Characteristics (SPC). Last updated 27 Mar 2026.

Onset of immunity: 2 weeks.
Duration of immunity: 7 months after primary vaccination.
1 year after revaccination.
AN: 02650/2024Page 2 of 6
Dogs can be vaccinated from the age of 6 weeks onwards.
Allow the vaccine to reach room temperature (15 °C – 25 °C) before use.
Primary vaccination:
Two vaccinations with an interval of 4 weeks.
Revaccination:
A single vaccination, administered 7 months after primary vaccination with this
vaccine, is sufficient to maintain protection against Bordetella bronchiseptica
further year. Thereafter, a single vaccination should be administered, annually. In
case revaccination at 7 months is missed, a single vaccination within 12 months after
primary vaccination is sufficient to extend protection against Bordetella
bronchiseptica for a further year.
AN: 02650/2024Page 4 of 6
This vaccine can also be used for revaccination in a schedule where Nobivac KC has
been used for primary vaccination. A single vaccination, administered one year after
primary vaccination with Nobivac KC, is sufficient to prolong immunity against
Bordetella bronchiseptica for another year.
Revaccination after primary vaccination with Nobivac KC:
One vaccination, annually.
For associated use:
When this vaccine is administered in associated use (i.e. not mixed) with another
vaccine in the Nobivac range as indicated under section 3.8, the vaccines should be
given subcutaneously, at the same time, at a different site. Dogs should not be
younger than the minimum age recommended for the other Nobivac vaccine, as stated
in the respective product information.
None.
Dogs:
Very common
(> 1 animal / 10 animals
treated):
Injection site swelling 2 cm, occasionally firm,
may be present up to 25 days post-vaccination).

Common
(1 to 10 animals / 100 animals
treated):
Injection site swelling 3.5 cm, may be present
up to 25 days post-vaccination
and can be
painful).
Very rare
(< 1 animal / 10,000 animals
treated, including isolated
reports):
Hypersensitivity reaction.
1
The swelling may uncommonly last for up to 35 days post-vaccination.
If hypersensitivity reaction occurs, appropriate treatment should be administered without
delay. Such reactions may evolve to a more severe condition which may be life-threatening.
Reporting adverse events is important. It allows continuous safety monitoring of a
veterinary medicinal product. Reports should be sent, preferably via a veterinarian, to
either the marketing authorisation holder or its local representative or the national
competent authority via the national reporting system. See also the last section of
the package leaflet for contact details.
Vaccinate healthy animals only.

Special precautions for safe use in the target species:
Not applicable.
Special precautions to be taken by the person administering the veterinary medicinal
product to animals:
Not applicable.
Special precautions for the protection of the environment:
Not applicable.
Safety and efficacy data are available which demonstrate that this vaccine can be
administered at the same time but not mixed with the live vaccines in the Nobivac
range against canine distemper, canine contagious hepatitis caused by canine
adenovirus type 1, canine parvovirus disease and respiratory disease caused by
canine adenovirus type 2, where authorised.
Safety data are available which demonstrate that this vaccine can be administered at
the same time but not mixed with the Nobivac range of vaccines mentioned above
together with the live Nobivac parainfluenza vaccine and the inactivated vaccines in
the Nobivac range against leptospirosis caused by L. interrogans
serovar Canicola, L. interrogans serogroup Icterohaemorrhagiae serovar
Copenhageni, serogroup Australis serovar Bratislava, and L. kirschneri
serogroup Grippotyphosa serovar Bananal/Lianguang.
In addition, for the live canine parainfluenza vaccine there are antibody response
data, and for the inactivated canine leptospirosis vaccines there are antibody
response data and other immunity data which support the use of the vaccine at the
same time but not mixed with the mentioned Nobivac range of vaccines.
When this vaccine is administered in association with the relevant Nobivac vaccines,
the demonstrated safety and efficacy claims of the vaccine are the same as when
this vaccine is administered alone.
The product information of the relevant Nobivac vaccines used in association with
this vaccine should be consulted before administration.
No information is available on the safety and efficacy of this vaccine when used with
any other veterinary medicinal product except the products mentioned above. A
decision to use this vaccine before or after any other veterinary medicinal product
therefore needs to be made on a case by case basis.
Store in a refrigerator (2 C – 8 C). Do not freeze.
Store in the original package in order to protect from light.
Not applicable.

This information is sourced from the official Summary of Product Characteristics (SPC) published by the Veterinary Medicines Directorate (VMD). It is provided for informational purposes only and does not replace professional veterinary advice. Always consult your vet before administering any medication.

Medication costs adding up?

Pet insurance can cover prescription medications. Find the right policy for your pet.

Compare insurance

Find cheaper vets near you

Compare vet consultation prices in your area. Save on procedures and get a prescription to buy medications online.